Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Gannett Q1 Profit Down - Quick Facts

RELATED NEWS
Trade GCI now with 

Gannett Co., Inc. (GCI: Quote) reported that its first-quarter net income attributable to the company declined to $68.22 million, from $90.49 million in the same quarter last year. Earnings per share, on a GAAP basis were $0.28 for the first quarter of 2012 compared to $0.37 for the first quarter last year.

Excluding special items in 2012 and 2011, first quarter earnings per share were $0.34 compared to $0.41 for the same quarter in 2011. Analysts polled by Thomson Reuters expected the company to report earnings of $0.31 per share for the quarter. Analysts' estimates typically exclude special items.

Total operating Revenues for the quarter declined to $1.22 billion from $1.25 billion in the prior year quarter. Seven analysts had consensus revenue estimate of $1.24 billion for the quarter.

Click here to receive FREE breaking news email alerts for Gannett Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After trending higher over the past several sessions, stocks showed a lack of direction throughout the trading day on Friday before closing roughly flat. A muted reaction to a highly anticipated speech by Federal Reserve Chair Janet Yellen contributed to the lackluster performance. Republican Scott Brown has significantly narrowed the gap in the race against incumbent New Hampshire Sen. Jeanne Shaheen, D-N.H., according to the results of a new WMUR Granite State Poll. On the heels of the violent clashes between local police and protestors in Ferguson, Missouri, Sen. Claire McCaskill, D-Mo., announced that she will hold a Senate hearing in September to examine the militarization of local police departments.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.